NO319686B1 - Renset og isolert polynukleotidsekvens, biologisk funksjonell DNA-vektor, vertscelle, fremgangsmate for fremstilling av et protocadherinpolypeptid, antistoffmateriale, hybridomcellelinje, anvendelse av protocadherin-PC3-fragment terapeutisk, en terapeutisk intervensjon samt antistoffmateriale eller protocadherin-PC3-fragment ifolge oppfinnelsen for anvendelse i en terapeutisk fremgangsmate. - Google Patents

Renset og isolert polynukleotidsekvens, biologisk funksjonell DNA-vektor, vertscelle, fremgangsmate for fremstilling av et protocadherinpolypeptid, antistoffmateriale, hybridomcellelinje, anvendelse av protocadherin-PC3-fragment terapeutisk, en terapeutisk intervensjon samt antistoffmateriale eller protocadherin-PC3-fragment ifolge oppfinnelsen for anvendelse i en terapeutisk fremgangsmate. Download PDF

Info

Publication number: NO319686B1
Authority: NO; Norway
Prior art keywords: protocadherin; cell; human; seq; cadherin
Prior art date: 1994-06-27

Application number

NO19960767A

Other languages

English (en)

Norwegian (no)

Other versions

NO960767L (no

NO960767D0 (no

Inventor

Shintaro Suzuki

Original Assignee

Doheny Eye Inst

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-06-27

Filing date

1996-02-26

Publication date

2005-09-05

1996-02-26 Application filed by Doheny Eye Inst filed Critical Doheny Eye Inst

1996-02-26 Publication of NO960767D0 publication Critical patent/NO960767D0/no

1996-04-26 Publication of NO960767L publication Critical patent/NO960767L/no

2005-09-05 Publication of NO319686B1 publication Critical patent/NO319686B1/no

Links

229920001184 polypeptide Polymers 0.000 title claims abstract description 22
102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 22
108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 22
239000000463 material Substances 0.000 title claims abstract description 20
108091033319 polynucleotide Proteins 0.000 title claims abstract description 16
239000002157 polynucleotide Substances 0.000 title claims abstract description 16
102000040430 polynucleotide Human genes 0.000 title claims abstract description 16
210000004027 cell Anatomy 0.000 title claims description 120
239000012634 fragment Substances 0.000 title claims description 35
239000013598 vector Substances 0.000 title claims description 13
230000001225 therapeutic effect Effects 0.000 title claims description 9
210000004408 hybridoma Anatomy 0.000 title claims description 8
238000002560 therapeutic procedure Methods 0.000 title claims description 6
238000000034 method Methods 0.000 title abstract description 22
238000002360 preparation method Methods 0.000 title description 7
230000027455 binding Effects 0.000 claims abstract description 16
230000001105 regulatory effect Effects 0.000 claims abstract description 8
238000004519 manufacturing process Methods 0.000 claims abstract description 7
241000282414 Homo sapiens Species 0.000 claims description 59
239000002299 complementary DNA Substances 0.000 claims description 45
230000014509 gene expression Effects 0.000 claims description 39
108020004414 DNA Proteins 0.000 claims description 26
108091028043 Nucleic acid sequence Proteins 0.000 claims description 23
230000017455 cell-cell adhesion Effects 0.000 claims description 9
239000001963 growth medium Substances 0.000 claims description 4
230000010261 cell growth Effects 0.000 claims description 3
239000002609 medium Substances 0.000 claims description 2
235000015097 nutrients Nutrition 0.000 claims description 2
238000012258 culturing Methods 0.000 claims 1
108700040559 Protocadherins Proteins 0.000 abstract description 18
238000009739 binding Methods 0.000 abstract description 12
239000000126 substance Substances 0.000 abstract 1
102000000905 Cadherin Human genes 0.000 description 79
108050007957 Cadherin Proteins 0.000 description 79
101000601855 Homo sapiens Protocadherin-1 Proteins 0.000 description 70
102100037551 Protocadherin-1 Human genes 0.000 description 69
108090000623 proteins and genes Proteins 0.000 description 43
241000700159 Rattus Species 0.000 description 42
210000001519 tissue Anatomy 0.000 description 34
102000004169 proteins and genes Human genes 0.000 description 29
235000018102 proteins Nutrition 0.000 description 27
125000003275 alpha amino acid group Chemical group 0.000 description 26
210000004556 brain Anatomy 0.000 description 26
108020004999 messenger RNA Proteins 0.000 description 23
238000003752 polymerase chain reaction Methods 0.000 description 21
230000001086 cytosolic effect Effects 0.000 description 18
239000000523 sample Substances 0.000 description 17
241000699666 Mus <mouse, genus> Species 0.000 description 15
238000009396 hybridization Methods 0.000 description 15
108010023070 Cadherin Related Proteins Proteins 0.000 description 14
102000011103 Cadherin Related Proteins Human genes 0.000 description 14
230000002776 aggregation Effects 0.000 description 14
238000004220 aggregation Methods 0.000 description 14
108020001507 fusion proteins Proteins 0.000 description 13
102000037865 fusion proteins Human genes 0.000 description 13
101000601993 Homo sapiens Protocadherin gamma-C3 Proteins 0.000 description 12
108050000637 N-cadherin Proteins 0.000 description 12
102100037560 Protocadherin gamma-C3 Human genes 0.000 description 12
239000000047 product Substances 0.000 description 12
239000011575 calcium Substances 0.000 description 10
235000001014 amino acid Nutrition 0.000 description 9
150000001413 amino acids Chemical class 0.000 description 9
210000002569 neuron Anatomy 0.000 description 9
239000003656 tris buffered saline Substances 0.000 description 9
108020004635 Complementary DNA Proteins 0.000 description 8
238000000636 Northern blotting Methods 0.000 description 8
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
238000004458 analytical method Methods 0.000 description 8
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 8
238000002955 isolation Methods 0.000 description 8
239000002953 phosphate buffered saline Substances 0.000 description 8
108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
206010029260 Neuroblastoma Diseases 0.000 description 7
238000002474 experimental method Methods 0.000 description 7
239000000284 extract Substances 0.000 description 7
238000007901 in situ hybridization Methods 0.000 description 7
230000004807 localization Effects 0.000 description 7
108700032759 Drosophila ft Proteins 0.000 description 6
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 6
241000283973 Oryctolagus cuniculus Species 0.000 description 6
210000000349 chromosome Anatomy 0.000 description 6
238000011161 development Methods 0.000 description 6
230000018109 developmental process Effects 0.000 description 6
239000012528 membrane Substances 0.000 description 6
239000002773 nucleotide Substances 0.000 description 6
125000003729 nucleotide group Chemical group 0.000 description 6
210000000449 purkinje cell Anatomy 0.000 description 6
230000009257 reactivity Effects 0.000 description 6
239000000243 solution Substances 0.000 description 6
238000005406 washing Methods 0.000 description 6
102000007469 Actins Human genes 0.000 description 5
108010085238 Actins Proteins 0.000 description 5
206010003571 Astrocytoma Diseases 0.000 description 5
101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 description 5
241000699670 Mus sp. Species 0.000 description 5
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 5
230000015572 biosynthetic process Effects 0.000 description 5
238000010367 cloning Methods 0.000 description 5
238000003119 immunoblot Methods 0.000 description 5
210000000963 osteoblast Anatomy 0.000 description 5
239000013612 plasmid Substances 0.000 description 5
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 4
229930040373 Paraformaldehyde Natural products 0.000 description 4
229920002684 Sepharose Polymers 0.000 description 4
102000004142 Trypsin Human genes 0.000 description 4
108090000631 Trypsin Proteins 0.000 description 4
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
210000001638 cerebellum Anatomy 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 4
230000001419 dependent effect Effects 0.000 description 4
230000029087 digestion Effects 0.000 description 4
238000009826 distribution Methods 0.000 description 4
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 4
230000000694 effects Effects 0.000 description 4
239000013604 expression vector Substances 0.000 description 4
210000002216 heart Anatomy 0.000 description 4
238000010820 immunofluorescence microscopy Methods 0.000 description 4
238000001727 in vivo Methods 0.000 description 4
239000003446 ligand Substances 0.000 description 4
210000004165 myocardium Anatomy 0.000 description 4
210000004498 neuroglial cell Anatomy 0.000 description 4
229920002866 paraformaldehyde Polymers 0.000 description 4
238000012216 screening Methods 0.000 description 4
239000011780 sodium chloride Substances 0.000 description 4
210000000130 stem cell Anatomy 0.000 description 4
239000012588 trypsin Substances 0.000 description 4
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
208000032116 Autoimmune Experimental Encephalomyelitis Diseases 0.000 description 3
102000016289 Cell Adhesion Molecules Human genes 0.000 description 3
108010067225 Cell Adhesion Molecules Proteins 0.000 description 3
108091035707 Consensus sequence Proteins 0.000 description 3
241000255581 Drosophila <fruit fly, genus> Species 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
101000984012 Gallus gallus Cadherin-1 Proteins 0.000 description 3
208000032612 Glial tumor Diseases 0.000 description 3
206010018338 Glioma Diseases 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
101000714535 Mus musculus Cadherin-2 Proteins 0.000 description 3
239000000020 Nitrocellulose Substances 0.000 description 3
108091034117 Oligonucleotide Proteins 0.000 description 3
241000276498 Pollachius virens Species 0.000 description 3
102000001742 Tumor Suppressor Proteins Human genes 0.000 description 3
108010040002 Tumor Suppressor Proteins Proteins 0.000 description 3
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
150000001298 alcohols Chemical class 0.000 description 3
AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 3
230000009134 cell regulation Effects 0.000 description 3
230000014107 chromosome localization Effects 0.000 description 3
210000002919 epithelial cell Anatomy 0.000 description 3
239000013613 expression plasmid Substances 0.000 description 3
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 3
230000006870 function Effects 0.000 description 3
230000001900 immune effect Effects 0.000 description 3
230000003053 immunization Effects 0.000 description 3
238000002649 immunization Methods 0.000 description 3
238000011534 incubation Methods 0.000 description 3
210000000265 leukocyte Anatomy 0.000 description 3
210000003632 microfilament Anatomy 0.000 description 3
229920001220 nitrocellulos Polymers 0.000 description 3
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 3
210000002235 sarcomere Anatomy 0.000 description 3
238000012163 sequencing technique Methods 0.000 description 3
238000001262 western blot Methods 0.000 description 3
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
102000005701 Calcium-Binding Proteins Human genes 0.000 description 2
108010045403 Calcium-Binding Proteins Proteins 0.000 description 2
102000000584 Calmodulin Human genes 0.000 description 2
108010041952 Calmodulin Proteins 0.000 description 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
206010027476 Metastases Diseases 0.000 description 2
101000984025 Mus musculus Cadherin-1 Proteins 0.000 description 2
241000699667 Mus spretus Species 0.000 description 2
206010028980 Neoplasm Diseases 0.000 description 2
-1 OCT compound Chemical class 0.000 description 2
239000002033 PVDF binder Substances 0.000 description 2
229920001213 Polysorbate 20 Polymers 0.000 description 2
108091034057 RNA (poly(A)) Proteins 0.000 description 2
238000012300 Sequence Analysis Methods 0.000 description 2
229930006000 Sucrose Natural products 0.000 description 2
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
102000044209 Tumor Suppressor Genes Human genes 0.000 description 2
108700025716 Tumor Suppressor Genes Proteins 0.000 description 2
241000269370 Xenopus <genus> Species 0.000 description 2
230000001070 adhesive effect Effects 0.000 description 2
239000002671 adjuvant Substances 0.000 description 2
239000011543 agarose gel Substances 0.000 description 2
238000000246 agarose gel electrophoresis Methods 0.000 description 2
125000000539 amino acid group Chemical group 0.000 description 2
230000000692 anti-sense effect Effects 0.000 description 2
238000000376 autoradiography Methods 0.000 description 2
239000011324 bead Substances 0.000 description 2
239000000872 buffer Substances 0.000 description 2
210000004899 c-terminal region Anatomy 0.000 description 2
230000021164 cell adhesion Effects 0.000 description 2
239000006285 cell suspension Substances 0.000 description 2
238000005119 centrifugation Methods 0.000 description 2
230000008045 co-localization Effects 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
210000004292 cytoskeleton Anatomy 0.000 description 2
238000001514 detection method Methods 0.000 description 2
DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 2
210000003195 fascia Anatomy 0.000 description 2
239000011521 glass Substances 0.000 description 2
210000004884 grey matter Anatomy 0.000 description 2
ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 2
210000005260 human cell Anatomy 0.000 description 2
210000004201 immune sera Anatomy 0.000 description 2
229940042743 immune sera Drugs 0.000 description 2
238000001114 immunoprecipitation Methods 0.000 description 2
238000011065 in-situ storage Methods 0.000 description 2
230000005764 inhibitory process Effects 0.000 description 2
230000005732 intercellular adhesion Effects 0.000 description 2
238000011031 large-scale manufacturing process Methods 0.000 description 2
210000004185 liver Anatomy 0.000 description 2
210000004072 lung Anatomy 0.000 description 2
238000013507 mapping Methods 0.000 description 2
230000009401 metastasis Effects 0.000 description 2
238000010369 molecular cloning Methods 0.000 description 2
239000003068 molecular probe Substances 0.000 description 2
210000003205 muscle Anatomy 0.000 description 2
210000000107 myocyte Anatomy 0.000 description 2
230000001537 neural effect Effects 0.000 description 2
229920002113 octoxynol Polymers 0.000 description 2
210000000956 olfactory bulb Anatomy 0.000 description 2
210000000056 organ Anatomy 0.000 description 2
210000002826 placenta Anatomy 0.000 description 2
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
229920002981 polyvinylidene fluoride Polymers 0.000 description 2
230000017854 proteolysis Effects 0.000 description 2
238000000746 purification Methods 0.000 description 2
238000012552 review Methods 0.000 description 2
210000000518 sarcolemma Anatomy 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
210000002027 skeletal muscle Anatomy 0.000 description 2
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
210000000278 spinal cord Anatomy 0.000 description 2
238000010561 standard procedure Methods 0.000 description 2
238000007920 subcutaneous administration Methods 0.000 description 2
239000005720 sucrose Substances 0.000 description 2
238000011144 upstream manufacturing Methods 0.000 description 2
108700026220 vif Genes Proteins 0.000 description 2
210000004885 white matter Anatomy 0.000 description 2
IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 description 1
BHNQPLPANNDEGL-UHFFFAOYSA-N 2-(4-octylphenoxy)ethanol Chemical compound CCCCCCCCC1=CC=C(OCCO)C=C1 BHNQPLPANNDEGL-UHFFFAOYSA-N 0.000 description 1
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
101150094949 APRT gene Proteins 0.000 description 1
102000010825 Actinin Human genes 0.000 description 1
108010063503 Actinin Proteins 0.000 description 1
102100029457 Adenine phosphoribosyltransferase Human genes 0.000 description 1
108010024223 Adenine phosphoribosyltransferase Proteins 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
229920000856 Amylose Polymers 0.000 description 1
206010003591 Ataxia Diseases 0.000 description 1
101710118833 B-cadherin Proteins 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
102100025805 Cadherin-1 Human genes 0.000 description 1
102100024154 Cadherin-13 Human genes 0.000 description 1
102100024153 Cadherin-15 Human genes 0.000 description 1
102100029758 Cadherin-4 Human genes 0.000 description 1
102000055006 Calcitonin Human genes 0.000 description 1
108060001064 Calcitonin Proteins 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
OYPRJOBELJOOCE-BKFZFHPZSA-N Calcium-45 Chemical compound [45Ca] OYPRJOBELJOOCE-BKFZFHPZSA-N 0.000 description 1
241000283707 Capra Species 0.000 description 1
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
102000016362 Catenins Human genes 0.000 description 1
108010067316 Catenins Proteins 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
108091026890 Coding region Proteins 0.000 description 1
108020004705 Codon Proteins 0.000 description 1
102000010831 Cytoskeletal Proteins Human genes 0.000 description 1
108010037414 Cytoskeletal Proteins Proteins 0.000 description 1
101710173353 Cytotoxicity-associated immunodominant antigen Proteins 0.000 description 1
108020003215 DNA Probes Proteins 0.000 description 1
239000003298 DNA probe Substances 0.000 description 1
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
102000016911 Deoxyribonucleases Human genes 0.000 description 1
108010053770 Deoxyribonucleases Proteins 0.000 description 1
102100036912 Desmin Human genes 0.000 description 1
108010044052 Desmin Proteins 0.000 description 1
102000011799 Desmoglein Human genes 0.000 description 1
108050002238 Desmoglein Proteins 0.000 description 1
101710162329 Dihydrofolate reductase 2 Proteins 0.000 description 1
102100033362 Dihydrofolate reductase 2, mitochondrial Human genes 0.000 description 1
206010013801 Duchenne Muscular Dystrophy Diseases 0.000 description 1
108010069091 Dystrophin Proteins 0.000 description 1
102000001039 Dystrophin Human genes 0.000 description 1
238000002965 ELISA Methods 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
206010015866 Extravasation Diseases 0.000 description 1
101150081880 FGF1 gene Proteins 0.000 description 1
102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
108010067306 Fibronectins Proteins 0.000 description 1
102000016359 Fibronectins Human genes 0.000 description 1
229920001917 Ficoll Polymers 0.000 description 1
238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 1
101000714545 Gallus gallus Cadherin-2 Proteins 0.000 description 1
235000010469 Glycine max Nutrition 0.000 description 1
244000068988 Glycine max Species 0.000 description 1
102100020948 Growth hormone receptor Human genes 0.000 description 1
108010066705 H-cadherin Proteins 0.000 description 1
239000007995 HEPES buffer Substances 0.000 description 1
102000001554 Hemoglobins Human genes 0.000 description 1
108010054147 Hemoglobins Proteins 0.000 description 1
101100118545 Holotrichia diomphalia EGF-like gene Proteins 0.000 description 1
241000282412 Homo Species 0.000 description 1
101000984015 Homo sapiens Cadherin-1 Proteins 0.000 description 1
101000714553 Homo sapiens Cadherin-3 Proteins 0.000 description 1
108060003951 Immunoglobulin Proteins 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
108010018562 M-cadherin Proteins 0.000 description 1
108010052285 Membrane Proteins Proteins 0.000 description 1
102000003792 Metallothionein Human genes 0.000 description 1
108090000157 Metallothionein Proteins 0.000 description 1
102000002151 Microfilament Proteins Human genes 0.000 description 1
108010040897 Microfilament Proteins Proteins 0.000 description 1
101000714552 Mus musculus Cadherin-3 Proteins 0.000 description 1
101100407584 Mus musculus Ptger2 gene Proteins 0.000 description 1
102000003505 Myosin Human genes 0.000 description 1
108060008487 Myosin Proteins 0.000 description 1
108010058846 Ovalbumin Proteins 0.000 description 1
239000007990 PIPES buffer Substances 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
241000609499 Palicourea Species 0.000 description 1
102000003982 Parathyroid hormone Human genes 0.000 description 1
108090000445 Parathyroid hormone Proteins 0.000 description 1
201000011152 Pemphigus Diseases 0.000 description 1
206010035226 Plasma cell myeloma Diseases 0.000 description 1
108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
108010076504 Protein Sorting Signals Proteins 0.000 description 1
108010086890 R-cadherin Proteins 0.000 description 1
108020004518 RNA Probes Proteins 0.000 description 1
239000003391 RNA probe Substances 0.000 description 1
102000006382 Ribonucleases Human genes 0.000 description 1
108010083644 Ribonucleases Proteins 0.000 description 1
108090000184 Selectins Proteins 0.000 description 1
102000003800 Selectins Human genes 0.000 description 1
108010068542 Somatotropin Receptors Proteins 0.000 description 1
108010090804 Streptavidin Proteins 0.000 description 1
108010006785 Taq Polymerase Proteins 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
101710162629 Trypsin inhibitor Proteins 0.000 description 1
229940122618 Trypsin inhibitor Drugs 0.000 description 1
206010064390 Tumour invasion Diseases 0.000 description 1
102000003970 Vinculin Human genes 0.000 description 1
108090000384 Vinculin Proteins 0.000 description 1
241000700605 Viruses Species 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
239000002253 acid Substances 0.000 description 1
210000002867 adherens junction Anatomy 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
238000001042 affinity chromatography Methods 0.000 description 1
230000019552 anatomical structure morphogenesis Effects 0.000 description 1
238000004873 anchoring Methods 0.000 description 1
238000000137 annealing Methods 0.000 description 1
239000005557 antagonist Substances 0.000 description 1
238000003556 assay Methods 0.000 description 1
239000012911 assay medium Substances 0.000 description 1
208000037896 autoimmune cutaneous disease Diseases 0.000 description 1
108010058966 bacteriophage T7 induced DNA polymerase Proteins 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
210000002459 blastocyst Anatomy 0.000 description 1
210000004958 brain cell Anatomy 0.000 description 1
230000004641 brain development Effects 0.000 description 1
239000007975 buffered saline Substances 0.000 description 1
238000010805 cDNA synthesis kit Methods 0.000 description 1
BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
229960004015 calcitonin Drugs 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000001110 calcium chloride Substances 0.000 description 1
235000011148 calcium chloride Nutrition 0.000 description 1
229910001628 calcium chloride Inorganic materials 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
230000009400 cancer invasion Effects 0.000 description 1
235000011089 carbon dioxide Nutrition 0.000 description 1
210000004413 cardiac myocyte Anatomy 0.000 description 1
230000024245 cell differentiation Effects 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
210000003169 central nervous system Anatomy 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
239000003184 complementary RNA Substances 0.000 description 1
238000010276 construction Methods 0.000 description 1
238000011109 contamination Methods 0.000 description 1
125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
210000005220 cytoplasmic tail Anatomy 0.000 description 1
230000007423 decrease Effects 0.000 description 1
239000007857 degradation product Substances 0.000 description 1
238000012217 deletion Methods 0.000 description 1
230000037430 deletion Effects 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
238000013461 design Methods 0.000 description 1
210000005045 desmin Anatomy 0.000 description 1
239000003599 detergent Substances 0.000 description 1
230000009025 developmental regulation Effects 0.000 description 1
229960000633 dextran sulfate Drugs 0.000 description 1
239000000032 diagnostic agent Substances 0.000 description 1
229940039227 diagnostic agent Drugs 0.000 description 1
239000005546 dideoxynucleotide Substances 0.000 description 1
FFYPMLJYZAEMQB-UHFFFAOYSA-N diethyl pyrocarbonate Chemical compound CCOC(=O)OC(=O)OCC FFYPMLJYZAEMQB-UHFFFAOYSA-N 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
239000003814 drug Substances 0.000 description 1
238000001035 drying Methods 0.000 description 1
230000005014 ectopic expression Effects 0.000 description 1
235000013601 eggs Nutrition 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
239000003623 enhancer Substances 0.000 description 1
210000003527 eukaryotic cell Anatomy 0.000 description 1
230000036251 extravasation Effects 0.000 description 1
239000012091 fetal bovine serum Substances 0.000 description 1
230000001605 fetal effect Effects 0.000 description 1
210000003754 fetus Anatomy 0.000 description 1
229940126864 fibroblast growth factor Drugs 0.000 description 1
238000000799 fluorescence microscopy Methods 0.000 description 1
WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Substances O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
230000008014 freezing Effects 0.000 description 1
238000007710 freezing Methods 0.000 description 1
230000004927 fusion Effects 0.000 description 1
102000054766 genetic haplotypes Human genes 0.000 description 1
239000003862 glucocorticoid Substances 0.000 description 1
125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
230000013595 glycosylation Effects 0.000 description 1
238000006206 glycosylation reaction Methods 0.000 description 1
125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
210000004565 granule cell Anatomy 0.000 description 1
238000000227 grinding Methods 0.000 description 1
210000001320 hippocampus Anatomy 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
238000003018 immunoassay Methods 0.000 description 1
102000018358 immunoglobulin Human genes 0.000 description 1
230000002055 immunohistochemical effect Effects 0.000 description 1
238000002513 implantation Methods 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
102000006495 integrins Human genes 0.000 description 1
108010044426 integrins Proteins 0.000 description 1
210000004692 intercellular junction Anatomy 0.000 description 1
210000005026 intestinal epithelial barrier Anatomy 0.000 description 1
230000009545 invasion Effects 0.000 description 1
238000011835 investigation Methods 0.000 description 1
BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
238000002372 labelling Methods 0.000 description 1
239000007788 liquid Substances 0.000 description 1
229910001629 magnesium chloride Inorganic materials 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
210000004925 microvascular endothelial cell Anatomy 0.000 description 1
239000000203 mixture Substances 0.000 description 1
239000004570 mortar (masonry) Substances 0.000 description 1
210000002161 motor neuron Anatomy 0.000 description 1
229940126619 mouse monoclonal antibody Drugs 0.000 description 1
210000000663 muscle cell Anatomy 0.000 description 1
230000004118 muscle contraction Effects 0.000 description 1
201000000050 myeloid neoplasm Diseases 0.000 description 1
210000000653 nervous system Anatomy 0.000 description 1
210000002241 neurite Anatomy 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
201000008968 osteosarcoma Diseases 0.000 description 1
229940092253 ovalbumin Drugs 0.000 description 1
239000000199 parathyroid hormone Substances 0.000 description 1
229960001319 parathyroid hormone Drugs 0.000 description 1
201000001976 pemphigus vulgaris Diseases 0.000 description 1
RLZZZVKAURTHCP-UHFFFAOYSA-N phenanthrene-3,4-diol Chemical compound C1=CC=C2C3=C(O)C(O)=CC=C3C=CC2=C1 RLZZZVKAURTHCP-UHFFFAOYSA-N 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
230000028742 placenta development Effects 0.000 description 1
229920000729 poly(L-lysine) polymer Polymers 0.000 description 1
238000006116 polymerization reaction Methods 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
239000002243 precursor Substances 0.000 description 1
230000035935 pregnancy Effects 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
238000012545 processing Methods 0.000 description 1
210000001236 prokaryotic cell Anatomy 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
AAEVYOVXGOFMJO-UHFFFAOYSA-N prometryn Chemical compound CSC1=NC(NC(C)C)=NC(NC(C)C)=N1 AAEVYOVXGOFMJO-UHFFFAOYSA-N 0.000 description 1
238000010298 pulverizing process Methods 0.000 description 1
210000002763 pyramidal cell Anatomy 0.000 description 1
238000010188 recombinant method Methods 0.000 description 1
230000009711 regulatory function Effects 0.000 description 1
230000003252 repetitive effect Effects 0.000 description 1
239000011347 resin Substances 0.000 description 1
229920005989 resin Polymers 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
108700038288 rhodamine-phalloidin Proteins 0.000 description 1
230000007017 scission Effects 0.000 description 1
238000005204 segregation Methods 0.000 description 1
235000020183 skimmed milk Nutrition 0.000 description 1
210000003491 skin Anatomy 0.000 description 1
239000011734 sodium Substances 0.000 description 1
239000007787 solid Substances 0.000 description 1
210000000952 spleen Anatomy 0.000 description 1
238000010186 staining Methods 0.000 description 1
238000012289 standard assay Methods 0.000 description 1
210000003518 stress fiber Anatomy 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
230000002123 temporal effect Effects 0.000 description 1
238000012360 testing method Methods 0.000 description 1
JGVWCANSWKRBCS-UHFFFAOYSA-N tetramethylrhodamine thiocyanate Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=C(SC#N)C=C1C(O)=O JGVWCANSWKRBCS-UHFFFAOYSA-N 0.000 description 1
229940124597 therapeutic agent Drugs 0.000 description 1
238000001890 transfection Methods 0.000 description 1
238000011426 transformation method Methods 0.000 description 1
230000001052 transient effect Effects 0.000 description 1
230000014621 translational initiation Effects 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
210000002993 trophoblast Anatomy 0.000 description 1
239000002753 trypsin inhibitor Substances 0.000 description 1
239000011534 wash buffer Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Zoology (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Cell Biology (AREA)
Toxicology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Steroid Compounds (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

NO19960767A 1994-06-27 1996-02-26 Renset og isolert polynukleotidsekvens, biologisk funksjonell DNA-vektor, vertscelle, fremgangsmate for fremstilling av et protocadherinpolypeptid, antistoffmateriale, hybridomcellelinje, anvendelse av protocadherin-PC3-fragment terapeutisk, en terapeutisk intervensjon samt antistoffmateriale eller protocadherin-PC3-fragment ifolge oppfinnelsen for anvendelse i en terapeutisk fremgangsmate. NO319686B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/268,161 US5798224A (en)	1992-12-29	1994-06-27	Nucleic acids encoding protocadherin
PCT/US1995/008071 WO1996000289A1 (en)	1994-06-27	1995-06-26	Protocadherin proteins and their uses

Publications (3)

Publication Number	Publication Date
NO960767D0 NO960767D0 (no)	1996-02-26
NO960767L NO960767L (no)	1996-04-26
NO319686B1 true NO319686B1 (no)	2005-09-05

Family

ID=23021746

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19960767A NO319686B1 (no)	1994-06-27	1996-02-26	Renset og isolert polynukleotidsekvens, biologisk funksjonell DNA-vektor, vertscelle, fremgangsmate for fremstilling av et protocadherinpolypeptid, antistoffmateriale, hybridomcellelinje, anvendelse av protocadherin-PC3-fragment terapeutisk, en terapeutisk intervensjon samt antistoffmateriale eller protocadherin-PC3-fragment ifolge oppfinnelsen for anvendelse i en terapeutisk fremgangsmate.

Country Status (18)

Country	Link
US (5)	US5798224A (zh)
EP (1)	EP0719330B1 (zh)
JP (1)	JP3560344B2 (zh)
CN (1)	CN1105187C (zh)
AT (1)	ATE309347T1 (zh)
AU (1)	AU699135B2 (zh)
BR (1)	BR9506058A (zh)
CA (1)	CA2170156A1 (zh)
CZ (1)	CZ288789B6 (zh)
DE (1)	DE69534588D1 (zh)
FI (1)	FI960888A0 (zh)
HU (1)	HU221637B1 (zh)
MX (1)	MX9600666A (zh)
NO (1)	NO319686B1 (zh)
PL (1)	PL182324B1 (zh)
RU (1)	RU2197525C2 (zh)
SK (1)	SK281413B6 (zh)
WO (1)	WO1996000289A1 (zh)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6458939B1 (en)	1996-03-15	2002-10-01	Millennium Pharmaceuticals, Inc.	Compositions and methods for the diagnosis, prevention, and treatment of neoplastic cell growth and proliferation
WO1998030584A2 (en) *	1997-01-09	1998-07-16	Genetics Institute, Inc.	Secreted proteins and polynucleotides encoding them
US20020137890A1 (en) *	1997-03-31	2002-09-26	Genentech, Inc.	Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU3908299A (en) *	1997-12-08	1999-06-28	Ontogeny, Inc.	Cadherin-like polypeptides, methods and compositions related thereto
EP2256204A1 (en) *	1997-12-10	2010-12-01	CSL Limited	Porphorymonas gingivalis polypeptides and polynucleotides
DK1241185T3 (da) *	1998-03-26	2005-04-25	Genentech Inc	Nucleinsyrer, der er opformeret i humane tumorer, samt beslægtede materialer og fremgangsmåder
US7481999B2 (en) *	1998-05-05	2009-01-27	Adherex Technologies, Inc.	Compounds and methods for modulating OB-cadherin-mediated function
US6680175B2 (en) *	1998-05-05	2004-01-20	Adherex Technologies, Inc.	Methods for diagnosing and evaluating cancer
US6472367B1 (en)	1998-05-05	2002-10-29	Adherex Technologies, Inc.	Compounds and methods for modulating OB-cadherin mediated cell adhesion
US6638911B1 (en)	1998-05-05	2003-10-28	Adherex Technologies Inc.	Compounds and methods for modulating desmosomal cadherin-mediated functions
US20050203025A1 (en) *	1998-05-05	2005-09-15	Adherex Technologies, Inc.	Compounds and methods for modulating nonclassical cadherin-mediated functions
US6277824B1 (en)	1998-07-10	2001-08-21	Adherex Technologies	Compounds and methods for modulating adhesion molecule function
US20030096951A1 (en) *	1998-08-14	2003-05-22	Kenneth Jacobs	Secreted proteins and polynucleotides encoding them
US7041807B1 (en)	1999-06-23	2006-05-09	Caprion Pharmaceuticals, Inc.	Antibodies to a YYX epitope of a mammalian prion protein
US6787136B1 (en)	1999-09-03	2004-09-07	The Brigham And Women's Hospital, Inc.	Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents
US7193050B2 (en)	2000-02-18	2007-03-20	Genentech, Inc.	Secreted and transmembrane polypeptides and nucleic acids encoding the same
CN1313328A (zh) *	2000-03-15	2001-09-19	上海博德基因开发有限公司	一种新的多肽——人原钙粘素14和编码这种多肽的多核苷酸
AU2001275306A1 (en) *	2000-06-06	2001-12-17	Genaissance Pharmaceuticals, Inc.	Haplotypes of the pcdh2 gene
US6790636B1 (en) *	2000-06-14	2004-09-14	The United States Of America As Represented By The Department Of Health And Human Services	Rapid fluorescent labeling of tissue for microdissection using fluorescent specific binding agents
JP2004504018A (ja) *	2000-07-19	2004-02-12	ファルマシア・アンド・アップジョン・カンパニー	β−セレクターゼ活性の基質およびアッセイ
US7122311B2 (en) *	2001-07-16	2006-10-17	Novartis Ag	Methods for determining the risk of developing asthma characterized by bronchial hyperresponsiveness
US20040072236A1 (en)	2002-09-27	2004-04-15	Neil Cashman	PrPSc -interacting molecules and uses thereof
WO2004048411A2 (en) *	2002-11-14	2004-06-10	Adherex Technologies, Inc.	Compounds and methods for modulating desmosomal and atypical cadherin-mediated cell adhesion
CN101492673B (zh) *	2008-01-25	2012-01-11	中国科学院上海生命科学研究院	非洲爪蟾xpapc基因启动子及其组织特异性增强子
CN102274506A (zh) *	2008-09-07	2011-12-14	苏州爱生基因有限公司	治疗或预防癌症的药物
CN102274509A (zh) *	2008-09-07	2011-12-14	苏州爱生基因有限公司	治疗或预防癌症的药物
CN102274503A (zh) *	2008-09-07	2011-12-14	苏州爱生基因有限公司	治疗或预防癌症的药物
CN102274490A (zh) *	2008-09-07	2011-12-14	苏州爱生基因有限公司	一种用于治疗或预防癌症的药物
CN102274501A (zh) *	2008-09-07	2011-12-14	苏州爱生基因有限公司	一种治疗或预防癌症的药物
CN102274489A (zh) *	2008-09-07	2011-12-14	苏州爱生基因有限公司	治疗或预防癌症的药物
CN102274507A (zh) *	2008-09-07	2011-12-14	苏州爱生基因有限公司	一种用于治疗或预防癌症的药物
CN102274499A (zh) *	2008-09-07	2011-12-14	苏州爱生基因有限公司	用于治疗或预防癌症的药物
MA33276B1 (fr) *	2009-04-20	2012-05-02	Oxford Biotherapeutics Ltd	Anticorps spécifiques à la cadhérine-17
WO2011115268A1 (ja) *	2010-03-18	2011-09-22	大日本住友製薬株式会社	腫瘍血管新生阻害剤
US8877188B2 (en)	2010-05-04	2014-11-04	The Brigham And Women's Hospital, Inc.	Detection and treatment of non-dermal fibrosis
US9534058B2 (en)	2012-02-08	2017-01-03	Abbvie Stemcentrx Llc	Anti-CD324 monoclonal antibodies and uses thereof
CN103194476A (zh) *	2013-04-07	2013-07-10	新乡医学院	鸡pcdh1基因部分片段的克隆、表达及多克隆抗体的制备
AU2015302959B2 (en) *	2014-08-12	2018-09-20	Novartis Ag	Anti-CDH6 antibody drug conjugates
US11097005B2 (en)	2014-12-15	2021-08-24	The Brigham And Women's Hospital, Inc.	Use of cadherin-11 antagonists to treat metabolic disorders and/or increase insulin sensitivity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH05500504A (ja) *	1989-09-27	1993-02-04	アテナ・ニュウロサイエンスィズ・インコーポレイテッド	細胞付着阻止のための組成物及び使用方法
DE69129760T2 (de) *	1990-10-30	1999-03-25	La Jolla Cancer Research Foundation, La Jolla, Calif.	T-cadherin-bindungsmolekül

1994
- 1994-06-27 US US08/268,161 patent/US5798224A/en not_active Expired - Fee Related
1995
- 1995-05-30 US US08/453,702 patent/US5891706A/en not_active Expired - Fee Related
- 1995-05-30 US US08/453,695 patent/US5708143A/en not_active Expired - Fee Related
- 1995-06-26 WO PCT/US1995/008071 patent/WO1996000289A1/en active IP Right Grant
- 1995-06-26 RU RU96105990/13A patent/RU2197525C2/ru not_active IP Right Cessation
- 1995-06-26 CZ CZ1996482A patent/CZ288789B6/cs not_active IP Right Cessation
- 1995-06-26 MX MX9600666A patent/MX9600666A/es unknown
- 1995-06-26 DE DE69534588T patent/DE69534588D1/de not_active Expired - Lifetime
- 1995-06-26 AU AU28724/95A patent/AU699135B2/en not_active Ceased
- 1995-06-26 BR BR9506058A patent/BR9506058A/pt not_active Application Discontinuation
- 1995-06-26 AT AT95924073T patent/ATE309347T1/de not_active IP Right Cessation
- 1995-06-26 CA CA002170156A patent/CA2170156A1/en not_active Abandoned
- 1995-06-26 JP JP50339096A patent/JP3560344B2/ja not_active Expired - Fee Related
- 1995-06-26 EP EP95924073A patent/EP0719330B1/en not_active Expired - Lifetime
- 1995-06-26 HU HU9600449A patent/HU221637B1/hu not_active IP Right Cessation
- 1995-06-26 SK SK252-96A patent/SK281413B6/sk unknown
- 1995-06-26 PL PL95313256A patent/PL182324B1/pl not_active IP Right Cessation
- 1995-06-26 CN CN95190790A patent/CN1105187C/zh not_active Expired - Fee Related
1996
- 1996-02-26 FI FI960888A patent/FI960888A0/fi not_active IP Right Cessation
- 1996-02-26 NO NO19960767A patent/NO319686B1/no unknown
1998
- 1998-06-18 US US09/099,639 patent/US6262237B1/en not_active Expired - Fee Related
2001
- 2001-06-13 US US09/880,573 patent/US20030139581A1/en not_active Abandoned

Also Published As

Publication number	Publication date
FI960888L (fi)	1996-02-26
SK25296A3 (en)	1997-02-05
NO960767L (no)	1996-04-26
US6262237B1 (en)	2001-07-17
HUT75825A (en)	1997-05-28
HU9600449D0 (en)	1996-04-29
WO1996000289A1 (en)	1996-01-04
CN1105187C (zh)	2003-04-09
AU2872495A (en)	1996-01-19
MX9600666A (es)	1997-06-28
HU221637B1 (hu)	2002-12-28
US5798224A (en)	1998-08-25
EP0719330A1 (en)	1996-07-03
DE69534588D1 (de)	2005-12-15
PL182324B1 (pl)	2001-12-31
CA2170156A1 (en)	1996-01-04
SK281413B6 (sk)	2001-03-12
CN1134172A (zh)	1996-10-23
US5708143A (en)	1998-01-13
JPH09505740A (ja)	1997-06-10
CZ288789B6 (cs)	2001-09-12
EP0719330B1 (en)	2005-11-09
JP3560344B2 (ja)	2004-09-02
CZ48296A3 (en)	1996-11-13
PL313256A1 (en)	1996-06-24
BR9506058A (pt)	1997-08-05
RU2197525C2 (ru)	2003-01-27
US5891706A (en)	1999-04-06
AU699135B2 (en)	1998-11-26
US20030139581A1 (en)	2003-07-24
NO960767D0 (no)	1996-02-26
ATE309347T1 (de)	2005-11-15
FI960888A0 (fi)	1996-02-26

Publication	Publication Date	Title
US5798224A (en)	1998-08-25	Nucleic acids encoding protocadherin
Honda et al.	2000	The coxsackievirus-adenovirus receptor protein as a cell adhesion molecule in the developing mouse brain
US5643781A (en)	1997-07-01	DNA encoding protocadherin-42
Lee et al.	1991	Molecular cloning and primary structure of Kell blood group protein.
US5639634A (en)	1997-06-17	Cadherin polynucleotides
US20090185979A1 (en)	2009-07-23	Integrin Heterodimer and an Alpha Subunit Thereof
Hasler et al.	1993	cDNA cloning, structural features, and eucaryotic expression of human TAG‐1/axonin‐1
WO1996004396A1 (en)	1996-02-15	Neural cell adhesion molecules, nucleotide sequences encoding the molecules, and methods of use thereof
JP2002517182A (ja)	2002-06-18	インテグリンヘテロ二量体およびそのサブユニット
LAPLANTE et al.	2000	Cloning of human Ca2+ homoeostasis endoplasmic reticulum protein (CHERP): regulated expression of antisense cDNA depletes CHERP, inhibits intracellular Ca2+ mobilization and decreases cell proliferation
JP4249927B2 (ja)	2009-04-08	コラーゲン様新規蛋白ｃｌａｃおよびその前駆体、ならびにそれらをコードする遺伝子
US20100234294A1 (en)	2010-09-16	Identification of new isoforms of the mhc-class i specific receptor cd160 and uses thereof
US20060024291A1 (en)	2006-02-02	Protocadherin materials and methods
US20040053364A1 (en)	2004-03-18	Human CMRF-35-H9 receptor which binds IgM
MXPA06014402A (es)	2007-03-08	Peptido de enlace a heparina.
JP2001508181A (ja)	2001-06-19	Ｉｃａｍ−４及びその診断用途
JP2004000237A (ja)	2004-01-08	新規蛋白質及びその製造方法
JP2001054393A (ja)	2001-02-27	新規タンパク質およびそのｄｎａ
JP2000184890A (ja)	2000-07-04	新規タンパク質およびそのｄｎａ